Events & Presentations

Investors

Events & Presentations

Upcoming Events
Date Event Details Remind Me
Oct 18, 2019 8:00 AM EDT
Arrowhead Analyst R&D Day 2019
New York, NY
Archived Events
Date Event Details
Sep 20, 2019 4:15 PM CEST
Molecular Therapies for Liver Disease in Alpha-1 Antitrypsin Deficiency
Naples, Italy
Sep 16, 2019 11:00 AM +04
Global Summit On Cardiology & Heart Diseases
Dubai, UAE
Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, will deliver a keynote presentation titled, “Treating hypertriglyceridemic states with RNA interference – emergence of an exciting new modality to treat cardiovascular diseases”
Sep 16, 2019
Developing Alpha-1 Antitrypsin Therapeutics; FDA Public Workshop
Bethesda, MD
Sep 14, 2019
Alpha-1 UK Support Group Event 2019
Daventry, Northamptonshire, UK
Sep 5, 2019
Citi’s 14th Annual Biotech Conference
Boston, MA
Sep 4, 2019 9:40 AM EDT
Baird's 2019 Global Healthcare Conference
New York, NY
Aug 12, 2019
BTIG Biotechnology Conference 2019
New York, NY
Aug 5, 2019 4:30 PM EDT
Arrowhead Pharmaceuticals 2019 Third Quarter Results
Jul 17, 2019
Roth RNA Revolution Conference
Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, and Vincent Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in panel discussions.
Jun 21, 2019
Alpha-1 National Conference
Orlando, FL
James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “ARO-AAT for Liver Disease in Alpha-1 Antitrypsin Deficiency: Progress in Clinical Development”